Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ANI Pharmaceuticals Inc ANIP

Healthcare
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ANIP)

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire November 8, 2024

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

GlobeNewswire November 4, 2024

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

GlobeNewswire October 30, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

GlobeNewswire October 25, 2024

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

GlobeNewswire October 24, 2024

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

GlobeNewswire September 26, 2024

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

GlobeNewswire September 16, 2024

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

GlobeNewswire September 16, 2024

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

GlobeNewswire September 13, 2024
View More News ››

Opinion & Analysis (NDAQ:ANIP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ANIP)

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financ

NEWS: $ANIP ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 GuidanceGenerated record quarterly...
whytestocks - November 8, 2024

Overweight Recommendation Issued On ANIP By Piper Sandler

News; $ANIP Overweight Recommendation Issued On ANIP By Piper Sandler2024-10-11 06:15:05 ET Piper Sandler analyst issues OVERWEIGHT...
whytestocks - October 11, 2024

ANIP Price Target Alert: $83.00. Issued by Raymond James

Just In: $ANIP ANIP Price Target Alert: $83.00. Issued by Raymond James2024-09-18 11:00:06 ET Gary Nachman from Raymond James issued a...
whytestocks - September 18, 2024

Outperform Recommendation Issued On ANIP By Raymond James

JUST IN: $ANIP Outperform Recommendation Issued On ANIP By Raymond James2024-09-18 10:30:03 ET Raymond James analyst issues OUTPERFORM...
whytestocks - September 18, 2024

Alimera Sciences stock rallies 75% on ANI Pharmaceuticals de

News; $ANIP Alimera Sciences stock rallies 75% on ANI Pharmaceuticals deal2024-06-24 08:08:29 ET Alimera Sciences Inc (NASDAQ: ALIM...
whytestocks - June 24, 2024
View more Bullboard ››

Tribe Property Technologies Inc.

Tribe Property Technologies Inc.

Tribe Property Technologies Inc. is a property technology company. The Company offers technology-enabled property management ...
View More »